OS Therapies Incorporated logo

OSTX Earnings Date: Nov 13, 2026 (Estimated) — OS Therapies Incorporated

AMEX · Healthcare · Biotechnology

Updated

Price $1.25
Market Cap $57.6M
P/E -1.1
52W Range $1.15 – $2.25
Next Earnings (est.)

When is OSTX's next earnings date?

OS Therapies Incorporated (OSTX) is expected to report earnings on Friday, November 13, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13 on revenue of $1.0M.

How did OSTX do in its last earnings report?

In its most recent report on Aug 17, 2026 (Q2 2026), OS Therapies Incorporated posted EPS of -$0.20 versus the -$0.23 estimate, a beat of 13.0%. Revenue was $0 against a $204,400 estimate. The stock's 1-day post-earnings move was -9.3%.

How much does OSTX stock move after earnings?

OSTX beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.4% (up or down) in the day after earnings.

About OS Therapies Incorporated

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-17Q2 2026-0.23-0.20+13.04%$0✅ Beat-9.26%-1.85%+9.88%
2026-08-14-0.18-0.20-12.36%—❌ Miss-8.13%-1.25%+6.25%
2026-05-18Q1 2026-0.19-0.27-42.11%$0❌ Miss-7.98%-7.98%-5.85%
2026-03-31Q4 2025-0.16-0.41-156.25%$0❌ Miss+6.01%-7.52%+22.56%
2025-11-17Q3 2025-0.13-0.21-61.54%$0❌ Miss-5.00%-5.00%-10.00%
2025-08-18Q2 2025-0.13-0.19-46.15%$0❌ Miss-1.38%+0.46%+0.92%
2025-03-31Q4 2024-0.14-0.24-71.43%$0❌ Miss-13.64%-7.14%+31.82%
2024-11-15Q3 2024-0.12-0.18-50.00%$0❌ Miss+0.00%-15.59%+58.18%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .